TFBS Bioscience (ROCO:6939) Other Current Payables: NT$33.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6939 TFBS Bioscience Inc ROCO:6939
48 GF Score
Price NT$20.30
GF Value NT$31.94
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is TFBS Bioscience Other Current Payables?

TFBS Bioscience ROCO:6939 48 Other Current Payables is NT$33.5 Mil as of Dec. 2025. GuruFocus rates ROCO:6939 with a GF Score™ of 48/100 and a GF Value™ of NT$31.94 (Possible Value Trap). The stock has 6 warning signs investors should review.

TFBS Bioscience's Other Current Payables for the quarter that ended in Dec. 2025 was NT$33.5 Mil.

TFBS Bioscience's quarterly Other Current Payables increased from Dec. 2024 (NT$37.7 Mil) to Jun. 2025 (NT$90.7 Mil) but then declined from Jun. 2025 (NT$90.7 Mil) to Dec. 2025 (NT$33.5 Mil).

TFBS Bioscience's annual Other Current Payables increased from Dec. 2023 (NT$29.8 Mil) to Dec. 2024 (NT$37.7 Mil) but then declined from Dec. 2024 (NT$37.7 Mil) to Dec. 2025 (NT$33.5 Mil).

TFBS Bioscience Other Current Payables Related Terms

TFBS Bioscience Other Current Payables Historical Data

* Premium members only.

The historical data trend for TFBS Bioscience's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Other Current Payables Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 15.84 23.93 29.80 37.74 33.47

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.80 31.02 37.74 90.68 33.47
ROCO:6939
48GF Score
TFBS Bioscience Inc ROCO:6939
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TFBS Bioscience Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$33.5 Mil mean?
TFBS Bioscience (ROCO:6939) has a Other Current Payables of NT$33.5 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on TFBS Bioscience and its competitors.
Is TFBS Bioscience's Other Current Payables too high?
TFBS Bioscience's current Other Current Payables is NT$33.5 Mil. Overall, TFBS Bioscience has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Other Current Payables compare to TMO and DHR?
TFBS Bioscience's Other Current Payables of NT$33.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on TFBS Bioscience and its competitors. TFBS Bioscience's current Other Current Payables is NT$33.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$31.94, compared to a current price of NT$20.30 — trading 36.4% below its estimated fair value. The current Other Current Payables is NT$33.5 Mil. TFBS Bioscience's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Other Current Payables is NT$33.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?

Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued. The current stock price of NT$20.30 is trading 36.4% below its estimated GF Value™ of NT$31.94. GuruFocus considers TFBS Bioscience to be Possible Value Trap.

Key valuation signals for ROCO:6939:

  • Other Current Payables: NT$33.5 Mil
  • GF Value™: NT$31.94 vs. price of NT$20.30 (36.4% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TFBS Bioscience Business Description

Address No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
48GF Score

Get the complete analysis for ROCO:6939

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.30
Price
NT$31.94
GF Value